Sublingual Caffeine on Reducing Recovery Time and Postoperative Agitation in Elderly Patients Undergoing General Anesthesia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorCairo University
About this trial
This study aims to evaluate the efficacy of sublingual caffeine in reducing recovery time and incidence of postoperative agitation in elderly patients undergoing general anesthesia.
Eligibility criteria
Qualifiers
Age ≥ 65 years.
Both sexes.
American Society of Anesthesiologists (ASA) physical status II.
Scheduled for elective ophthalmology surgery under general anesthesia.
Disqualifiers
History of severe cardiac arrhythmias or uncontrolled hypertension.
ASA III patients were excluded to reduce the risk of adverse events in elderly patients with severe systemic diseases.
Known allergy or hypersensitivity to caffeine.
Pre-existing cognitive impairment or dementia (All patients will undergo preoperative cognitive screening using the online Mini-Cog test or Montreal Cognitive Assessment [MoCA]).
Trial design
Treatments tested in this trial
- Caffine citrate
- Placebo
Treatment groups
50 Participants
are divided into 2 treatment groupsLocations
1Cairo University12613, Cairo Egypt
Sponsors and collaborators
Cairo University
Lead sponsor
Source ClinicalTrials.gov